![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect
![Developing a national, Web-based, patient-focused, prostate cancer data monitoring system | THE "NEW" PROSTATE CANCER INFOLINK Developing a national, Web-based, patient-focused, prostate cancer data monitoring system | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2009/12/mskcc-image-d.jpg?w=584)
Developing a national, Web-based, patient-focused, prostate cancer data monitoring system | THE "NEW" PROSTATE CANCER INFOLINK
![PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL | Indonesian Journal of Urology PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL | Indonesian Journal of Urology](http://juri.urologi.or.id/public/journals/1/cover_issue_38_en_US.jpg)
PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL | Indonesian Journal of Urology
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/5-Figure2-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
Indonesian Prostate Cancer Risk Calculator (IPCRC): An application for Predicting Prostate Cancer Risk (a Multicenter Study)
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1c.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-017-2150-1/MediaObjects/345_2017_2150_Fig2_HTML.gif)
Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink
![IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis](https://www.mdpi.com/ijms/ijms-20-01637/article_deploy/html/images/ijms-20-01637-g001.png)
IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
![Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.](https://d3i71xaburhd42.cloudfront.net/cfb41af6cecfb5f204e79875232cee8734801010/3-Table3-1.png)
Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
![Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/adf2d3f5-f120-4033-88a6-3fc175a7a0aa/gr1.jpg)